Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
VS-6766 + Cetuximab for Colorectal Cancer
Recruiting2 awardsPhase 1 & 2
Chicago, Illinois
This trial is testing the safety of combining a new drug (VS-6766) with an existing drug (cetuximab) to treat colorectal cancer. It's for people whose cancer has progressed despite other treatments, or who can't take/tolerate other treatments. If you participate, you'll be in the trial for up to 2 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.